FR940527-2-00074 FR940527-2-00063 National Institute of Allergy and Infectious Diseases; Meetings: National Advisory Allergy and Infectious Diseases Council; Acquired Immunodeficiency Syndrome Subcommittee; Allergy and Immunology Subcommittee; Microbiology and Infectious Diseases Subcommittee Pursuant to Public Law 92&hyph;463, notice is hereby given of the meeting of the National Advisory Allergy and Infectious Diseases Council, National Institute of Allergy and Infectious Diseases, and its subcommittees on June 16&hyph;17, 1994. Meetings of the Council, NAAIDC Allergy and Immunology Subcommittee and the NAAIDC Microbiology and Infectious Diseases Subcommittee will be held at the National Institutes of Health, Building 31C, Bethesda, Maryland. The meeting of the NAAIDC Acquired Immunodeficiency Syndrome Subcommittee will be held in the Crystal Ballroom, Hyatt Regency Bethesda Hotel, One Bethesda Metro Center, Bethesda, Maryland. The meeting of the full Council will be open to the public on June 16 in Conference Room 6 from approximately 2 p.m. until 4:30 p.m. for opening remarks of the Institute Director, discussion of procedural matters, Council business, and a report from the Institute Director which will include a discussion of budgetary matters. The primary program will include a report on the assessment of the NIH Intramural Research Program, an overview of reorganization plans within the Division of AIDS, an update on Institute reinvention experiments, and remarks by the Director, NIH. On June 17 the meetings of the NAAIDC Allergy and Immunology Subcommittee and NAAIDC Microbiology and Infectious Diseases Subcommittee will be open to the public from 8:30 a.m. until adjournment. The subcommittee will meet in conference rooms 7 and 6 respectively. The meeting of the NAAIDC Acquired Immunodeficiency Syndrome Subcommittee will be open to the public from 8 a.m. until adjournment on June 17. The subcommittee will meet in the Crystal Ballroom, Hyatt Regency Bethesda Hotel, One Bethesda Metro Center, Bethesda, Maryland. In accordance with the provisions set forth in secs. 552(c)(4) and 552b(c)(6), Title 5, U.S.C. and section 10(d) of Public Law 92&hyph;463, the meeting of the NAAIDC Acquired Immunodeficiency Syndrome Subcommittee, NAAIDC Allergy and Immunology Subcommittee and the NAAIDC Microbiology and Infectious Diseases Subcommittee will be closed to the public for approximately four hours for review, evaluation, and discussion of individual grant applications. It is anticipated that this will occur from 8:30 a.m. until approximately 2 p.m. on June 16, in conference rooms 6, 7 and 8 respectively. The meeting of the full Council will be closed from 4:30 p.m. until recess on June 16 for the review, discussion, and evaluation of individual grant applications. These applications and the discussions could reveal confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the applications, disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Ms. Claudia Goad, Committee Management Officer, National Institute of Allergy and Infectious Diseases, Solar Building, room 3C26, National Institutes of Health, Bethesda, Maryland 20892, 301&hyph;496&hyph;7601, will provide a summary of the meeting and a roster of committee members upon request. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should contact Ms. Goad in advance of the meeting. Dr. John J. McGowan, Director, Division of Extramural Activities, NIAID, NIH, Solar Building, room 3C20, 6003 Executive Boulevard, Rockville, Maryland 20892, telephone 301&hyph;496&hyph;7291, will provide substantive program information. (Catalog of Federal Domestic Assistance Program Nos. 93.855 Immunology, Allergic and Immunologic Diseases Research, 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health). Dated: May 20, 1994. Susan K. Feldman, Committee Management Officer, NIH. [FR Doc. 94&hyph;12970 Filed 5&hyph;26&hyph;94; 8:45 am] BILLING CODE 4140&hyph;01&hyph;M
